NeueHealth Q4 EPS $(30.47) Misses $(4.16) Estimate, Sales $292.87M Beat $283.44M Estimate
Portfolio Pulse from Benzinga Newsdesk
NeueHealth reported a Q4 EPS loss of $(30.47), significantly missing the $(4.16) estimate. However, their sales of $292.87M exceeded the $283.44M estimate.
March 06, 2024 | 11:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NeueHealth's Q4 earnings report showed a significant miss on EPS but a beat on sales estimates.
The substantial miss on the EPS estimate by over 632% is likely to negatively impact investor sentiment and stock price in the short term, despite the sales beat. The magnitude of the miss suggests underlying issues that could concern investors, overshadowing the positive sales performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100